It possesses in vitro balanced GIPR (EC50 = 3 pM) and GLP-1R (EC50 = 5 pM) agonism with relative activity seven times that of GIP to GIPR and five times that of GLP-1 to GLP-1R, respectively ( max at 5.4 nM with a single dose of 1.8 mg (106) and C max at 12 nM at the steady state with a daily dose of 2 mg in patients with T2DM (107)
In one study with body composition assessed for a subgroup, lean body mass (which includes muscle and bone) accounted for nearly 40% of the weight lost
Cardiovascular symptoms including chest pain, irregular heartbeat, severe pounding heart, dizziness, or near-fainting need immediate medical attention
Quicksilvers GLP-1 Support Bundle features products designed to support healthy digestive function, motility, detoxification, and nutrient status while actively using GLP-1s
Avoiding general anesthesia allows for a safer and more efficient experience for appropriately selected patients